Research Article

Synergic Interaction of Rifaximin and Mutaflor (Escherichia coli Nissle 1917) in the Treatment of Acetic Acid-Induced Colitis in Rats

Table 2

Influence of treatment with Escherichia coli Nissle 1917 (Mutaflor) and/or rifaximin and induction of colitis on the total number of Escherichia coli identified by qPCR in feces samples.

Experimental groupsThe number of bacteria (CFU/g)

Control2.41 × 105 ± 7.59 × 104
Mutaflor6.42 × 106 ± 3.21 × 106
Rifaximin2.95 × 102 ± 1.69 × 102
Rifaximin + Mutaflor5.54 × 104 ± 2.28 × 104
Colitis + NaCl7.57 × 108 ± 4.38 × 
Colitis + Mutaflor1.11 × 107 ± 4.22 × 
Colitis + rifaximin1.27 × 103 ± 6.68 × 
Colitis + rifaximin + Mutaflor4.52 × 105 ± 1.68 × 

Mean value ± SEM. observations in each experimental group. compared to control; compared to colitis + NaCl.